ESMC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ESMC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Escalon Medical's Operating Income for the three months ended in Dec. 2024 was $0.26 Mil. Escalon Medical's Interest Expense for the three months ended in Dec. 2024 was $-0.01 Mil. Escalon Medical's interest coverage for the quarter that ended in Dec. 2024 was 51.20. The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Escalon Medical's Interest Coverage or its related term are showing as below:
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Escalon Medical's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Escalon Medical Annual Data | |||||||||||||||||||||
Trend | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | Jun24 | |||||||||||
Interest Coverage | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | 21.77 | - |
Escalon Medical Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Interest Coverage | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | 34.50 | - | 51.20 |
For the Medical Devices subindustry, Escalon Medical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
If Interest Expense is negative and Operating Income is positive, then
Interest Coverage | = | -1 | * | Operating Income | / | Interest Expense |
Else if Interest Expense is negative and Operating Income is negative, then
The company did not have earnings to cover the interest expense. |
Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then
The company had no debt (1). |
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Escalon Medical's Interest Coverage for the fiscal year that ended in Jun. 2024 is calculated as
Here, for the fiscal year that ended in Jun. 2024, Escalon Medical's Interest Expense was $-0.02 Mil. Its Operating Income was $-0.10 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.28 Mil.
Escalon Medical did not have earnings to cover the interest expense. |
Escalon Medical's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as
Here, for the three months ended in Dec. 2024, Escalon Medical's Interest Expense was $-0.01 Mil. Its Operating Income was $0.26 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.25 Mil.
Interest Coverage | = | -1 | * | Operating Income (Q: Dec. 2024 ) | / | Interest Expense (Q: Dec. 2024 ) |
= | -1 | * | 0.256 | / | -0.005 | |
= | 51.20 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's Financial Strength is.
Escalon Medical (OTCPK:ESMC) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Thank you for viewing the detailed overview of Escalon Medical's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.
David James Jacovini | director | 120 PINE STREET, PHILADELPHIA PA 19106 |
John Dogum | director | 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103 |
Richard J Depiano | director | 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087 |
Lisa A Napolitano | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
C Sean Closkey | director | 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103 |
C Todd Trusk | director | 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301 |
Robert Michael O'connor | officer: Chief Financial Officer | 53 SORREL RUN, MT. LAUREL NJ 08054 |
Anthony J Coppola | director | 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205 |
Federman Jay L Md | director | 501 N. ESSEX AVENUE, NARBERTH PA 19072 |
Kwan William L G | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
Mark Wallace | officer: Chief Operating Officer | 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087 |
Fred G Choate | director | 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080 |
Depiano Richard J Jr | officer: President | 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087 |
Berkowitz David | officer: Principal Accounting Officer | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
Mark H Karsch | officer: CFO | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
From GuruFocus
By gurufocus • 05-15-2009
By gurufocus 10qk • 11-15-2010
By gurufocus • 02-18-2009
By gurufocus 10qk • 05-20-2010
By gurufocus 10qk • 10-12-2010
By gurufocus 10qk • 11-16-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.